Next, to determine the expression levels of AKT2 in clinical BC specimens and adjacent normal tissues, qRT-PCR assay was performed to detect AKT2 expression levels in tissues, then analyzed by densitometric measurement and normalized to the GAPDH expression levels. This evidence concerns the gene AKT2 and breast cancer.